5th Floor, Brigade Towers,
Financial District, Gachibowli,
Hyderabad - 500032,
The market is segmented by Product (MRI, Computed Tomography, Ultrasound, X-Ray, Nuclear Imaging, Fluoroscopy, and Mammography), Application and End User.
The United Kingdom Diagnostic Imaging Equipment market size is anticipated to expand at a CAGR of 5.5% during the forecast period. Certain factors that are driving the market growth include the prevalence of chronic diseases, growing adoption of advanced technologies in medical imaging, and an increase in the geriatric population.
The geriatric population is more prone to musculoskeletal diseases and joint problems. Osteoarthritis is the most common problem for old age people of more than 65 years and is accompanied by increased mortality, and decreased quality of life. The regional rise in incidence of chronic and life-threatening diseases are the major drivers for the market.
The emergence of automated diagnostic imaging scanners and on-going R&D development in diagnostic imaging are also expected to propel the market growth. In spite of these factors driving the market, there are other factors restraining the growth of the market, such as expensive procedures and equipment, and certain side effects of diagnostic imaging procedures.
Diagnostic imaging is the process of making a visual representation of the interior of a body for medical intervention. These equipment help in establishing a database of normal anatomy and physiology of internal organs, so that any abnormality can be noticed immediately. The ability to create pictures of a patient’s internal anatomy and convert them to film through diagnostic imaging has revolutionized the way many diseases and injuries are detected, diagnosed, and treated. This market has applications in various medical fields, like cardiology, oncology, neurology, and orthopedics.
Report scope can be customized per your requirements. Click here.
Oncology deals with diagnosis and treatment of tumors and cancers, which is one the leading causes of morbidity and mortality. According to the Cancer Research UK, there are more than 367,167 new cancer cases in the United Kingdom every year, which is nearly 990 every day (2015-2017).
Every two minutes, someone in the United Kingdom is diagnosed with cancer. Moreover, breast, prostate, lung, and bowel cancers, together, accounted for over half (53%) of all new cancer cases in the the country, in 2018. Each year, more than a third (36%) of all cancer cases, in the country, are diagnosed in people aged 75 years and over (2015-2017). Incidence rates for all cancers combined, in the United Kingdom, are the highest in people aged between 85 and 89 years. Thus, diagnostic imaging plays a vital role in oncology as tools, such as CT, are the highly beneficial and preferred method of imaging for many conditions.
To understand key trends, Download Sample Report
The market studied is consolidated owing to the presence of a few major players in the market. The market players are focusing on R&D to develop the technologically advanced products in order to reduce the cost and side effects associated with the products. The barriers for the new entrants are high in this industry, and hence few major market players hold the maximum market share.
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rise in the Prevalence of Chronic Diseases
4.2.2 Growing Adoption of Advanced Technologies in Medical Imaging
4.2.3 Increase in the Geriatric Population
4.3 Market Restraints
4.3.1 Expensive Procedures and Equipment
4.4 Porter's Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION
5.1 By Modality
5.1.2 Computed Tomography
5.1.5 Nuclear Imaging
5.2 By Application
5.2.7 Other Applications
5.3 By End-User
5.3.2 Diagnostic Centers
6. COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Carestream Health Inc.
6.1.2 Esaote SpA
6.1.3 Fujifilm Holdings Corporation
6.1.4 GE Healthcare
6.1.5 Hitachi, Ltd.
6.1.6 Hologic Inc.
6.1.7 Koninklijke Philips N.V.
6.1.8 Shimadzu Corporation
6.1.9 Siemens AG
6.1.10 Sonosite Inc.
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
** Subject to Availability
**Competitive Landscape Covers - Business Overview, Financials, Products and Strategies, and Recent Developments